Voting
Your vote is important!
Please be sure to vote your shares online now or vote by phone by dialing
866-437-3716.
The secure way to view our annual documents and to vote your shares.
View our annual report summarizing our financial and operational performance for the past year.
View our proxy statement outlining key information about the upcoming shareholder meeting.
Please be sure to vote your shares online now or vote by phone by dialing
866-437-3716.
This year's annual meeting will be available via virtual webcast.
May 23, 2024
2:30 PM Pacific Time
*Note: You must register to be eligible to participate in the meeting.
Maravai LifeSciences is a leading life sciences company providing critical products to enable the development of novel vaccines, drug therapies, and diagnostics, and to support research on human diseases. Our customers include top global biopharmaceutical companies and many other emerging biopharmaceutical and life sciences research companies, as well as leading academic research institutions and in vitro diagnostics companies. Our products address the key phases of biopharmaceutical development spanning research to commercialization and include complex nucleic acids for vaccine, therapeutic and diagnostic applications, custom enzymes for research and diagnostic use and antibody-based products to detect impurities during the production of biopharmaceutical products. We provide products that support our customers from discovery through commercialization of their vaccines, therapeutic agents and in vitro diagnostic products. Our products are offered under the following brands:
TriLink BioTechnologies is a global leader in RNA synthesis and scale up, including mRNA production, yield-enhancing proprietary CleanCap® mRNA capping technology, and CDMO services ranging from research to GMP grades.
Glen Research leads in specialty reagents for DNA and RNA oligonucleotide synthesis for a broad range of applications.
Cygnus Technologies developed the market for bioprocess impurity detection, process-related impurity analytics and viral clearance prior to human trials, regulatory approval and commercial release.
Alphazyme is a manufacturer of molecular biology enzymes, featuring a growing portfolio of enzymes used in the fields of molecular diagnostics and nucleic acid therapies.